Clinical Trials
11
Active:9
Completed:1
Trial Phases
3 Phases
Phase 1:9
Phase 3:1
Phase 4:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (11 trials with phase data)• Click on a phase to view related trials
Phase 1
9 (81.8%)Phase 3
1 (9.1%)Phase 4
1 (9.1%)A Study Comparing the Local Tolerability of Two Subcutaneous Heparins in Healthy Volunteers.
- First Posted Date
- 2019-02-15
- Last Posted Date
- 2019-02-15
- Lead Sponsor
- Aspen Global Incorporated
- Target Recruit Count
- 15
- Registration Number
- NCT03841396
Open-Label, Randomised, Active Controlled, Multi-Centre Phase 3 Study Safety and Efficacy of Danaparoid vs Argatroban
Phase 3
Terminated
- Conditions
- Heparin-induced Thrombocytopenia
- Interventions
- First Posted Date
- 2019-01-18
- Last Posted Date
- 2022-12-08
- Lead Sponsor
- Aspen Global Incorporated
- Target Recruit Count
- 7
- Registration Number
- NCT03809481
- Locations
- 🇺🇸
Shands University of Florida, Gainesville, Florida, United States
🇺🇸University of Minnesota Medical Center, Minneapolis, Minnesota, United States
🇺🇸Duke University Medical Center, Durham, North Carolina, United States
News
No news found